Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis.
Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis.
复制标题
DOI:
10.1002/art.39681
复制
发表时间:
2016-09
期刊:
影响因子:
--
通讯作者:
Rosenbaum JT
中科院分区:
文献类型:
--
作者:
Asquith MJ;Stauffer P;Davin S;Mitchell C;Lin P;Rosenbaum JT
The HLA-B27/β2 microglobulin (β2m) transgenic rat is a leading model of B27-associated spondyloarthopathy and disease is dependent on the presence of intestinal bacteria. We have shown previously that adult HLA-B27/β2m rats have an altered intestinal microbiota. In this study we sought to better define age-dependent changes to both mucosal immune function and dysbiosis in this model. Intestinal contents were collected from wild type and HLA-B27/β2m+ rats post-weaning (3 and 6 weeks), at disease onset (10 wks) and after the establishment of disease (16 wks). Microbial community structure was determined by 16s sequencing and qRT-PCR. Mucosal and systemic Th1, Th17 and Treg responses were analyzed by flow cytometry, as was the frequency of IgA-coated intestinal bacteria. Intestinal expression of inflammatory cytokines and antimicrobial peptides (AMPs) was determined by qRT-PCR. An inflammatory cytokine signature and elevated AMP expression during the post-weaning period preceded the development of clinical bowel inflammation and dysbiosis in HLA-B27/β2m+ rats. An early and sustained expansion of the Th17 pool was specifically observed in cecal and colonic mucosa of HLA-B27/β2m rats. Strongly elevated Akkermansia mucinphilia colonization and IgA coating of intestinal bacteria was significantly associated with HLA-B27 expression and arthritis development. HLA-B27/β2m expression in this rat model renders the host hyper-responsive to microbial antigens from infancy. Early activation of innate immunity and expansion of a mucosal Th17 signature are soon followed by dysbiosis in HLA-B27/β2m+ve animals. Perturbed mucosal immunity and dysbiosis strongly merit further study in both pre-diseased and diseased SpA patient populations.
登录
查看更多内容
DOI:
10.1016/j.berh.2014.10.018
发表时间:
2014-10
期刊:
Best practice & research. Clinical rheumatology
影响因子:
--
作者:
Asquith M;Elewaut D;Lin P;Rosenbaum JT
通讯作者:
Rosenbaum JT
DOI:
10.1126/science.1198469
发表时间:
2011-01-21
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Atarashi K;Tanoue T;Shima T;Imaoka A;Kuwahara T;Momose Y;Cheng G;Yamasaki S;Saito T;Ohba Y;Taniguchi T;Takeda K;Hori S;Ivanov II;Umesaki Y;Itoh K;Honda K
通讯作者:
Honda K
DOI:
10.1073/pnas.1219451110
发表时间:
2013-05-28
影响因子:
11.1
作者:
Everard, Amandine;Belzer, Clara;Cani, Patrice D.
通讯作者:
Cani, Patrice D.
影响因子:
5.2
作者:
Derrien M;Van Baarlen P;Hooiveld G;Norin E;Müller M;de Vos WM
通讯作者:
de Vos WM
影响因子:
30.3
作者:
Gevers D;Kugathasan S;Denson LA;Vázquez-Baeza Y;Van Treuren W;Ren B;Schwager E;Knights D;Song SJ;Yassour M;Morgan XC;Kostic AD;Luo C;González A;McDonald D;Haberman Y;Walters T;Baker S;Rosh J;Stephens M;Heyman M;Markowitz J;Baldassano R;Griffiths A;Sylvester F;Mack D;Kim S;Crandall W;Hyams J;Huttenhower C;Knight R;Xavier RJ
通讯作者:
Xavier RJ